Perspectives approach to the assessment of the quality of the vaccine plague live in terms of immunogenicity. Epidemiology and Vaccinal Prevention

Research objective – studying of a possibility of application antigen – stimulated cellular in vitro tests and technology of the cytometric analysis for control of immunogene activity of batches of vaccine plague live.

Materials and methods. As biomodels used white laboratory mice, immunized commercial medicine of vaccine of the plague NIIEG line, live from a strain of Yersinia pestis EV, in doses – 8 х 102, 4 х 103, 2 х 104 and 1 х 105 of living microbic cells. Blood for a research was taken from intact mice and on 7, 14 and 21 days after immunization. The intensity of an antigenreaktivnost of lymphocytes was defined in cellular in vitro tests, analyzing a marker of early activation (CD45+CD3+CD25+) of lymphocytes with use of the monoclonal antibodies conjugated from fluorokhroma. As specific antigen used a complex of water-soluble antigens of a plague microbe.

Results. As a result of a research it is shown that at the animals vaccinated by doses 4 х 103 – 1 х 105 living microbic cells, the highest level of an expression activation marker lymphocytes at anti-gene stimulation of in vitro is registered on 14 days after immunization, at the same time the quantity of CD25 – positive lymphocytes are on average 6.8 times higher, than in control group. High degree of direct link (coefficient of correlation of r = 1,000) quantities of the survived animals with increase in level of lymphocytes, expressiruyushchy markers of early activation – CD25 is established.

Conclusions. The offered technique can be used as the additional test when studying degree of immunogenicity of new (kandidatny) vaccines against plague.

1. Pharmacopoeial article of the enterprise FSP 42-8654-07 LSR-005759/08-220708 Vaccine plague alive, lyophilizate for the preparation of suspension for injections, cutaneous scarification and inhalation; 2007. (In Russ.)

2. Aparin GP, Vershinina TI. Methodological recommendations for determining the degree of immunogenicity of avirulent strains of plague microbe for white mice. Irkutsk; 1984. (In Russ.)

3. Kostyuchenko MV, Ponomarenko DG, Rakitina EL, et al. The prospect of evaluating the antigen reactivity of lymphocytes in vitro for the diagnosis of acute brucellosis. Infekciya i immunitet [Infection and immunity]. 2017;7(1):91–96. (In Russ.)

4. Ryzhikova SL, Druzhinina YuG, Ryabicheva TG, et al. Production of cytokines by blood cells as an indicator of the intensity of postvaccinal cellular immunity. Citokiny i vospalenie [Cytokines and inflammation]. 2009;8(1):57–61. (In Russ.)

5. Sarkisyan NS, Ponomarenko DG, Logvinenko OV, et al. Intensity of specific sensitization and immune status in patients with brucellosis. Medicinskaya immunologiya [Medical immunology]. 2016;18(4):365–372. (In Russ.)

6. Shchukovskaya TN, Firstova VV, Kravtsov AL. Evaluation of acquired immunity against anthrax in terms of the degree of damage of blood leukocytes in vitro with anthraxin. Problemy osobo opasnyh infekcij [Problems of Particularly Dangerous Infections]. 2007;93:81–84. (In Russ.)

7. Kulichenko AN, Abzaeva NV, Gostishcheva SE, et al. Use of antigen-specific cell tests in vitro to assess the formation of post-vaccinal antiplague immunity. Infekciya i immunitet [Infection and immunity]. 2017;7(2):203–208. (In Russ.)

8. Sakaguchi S. Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self. J Nat Immunol. 2005; 6(4):345–352. doi: 10.1038/ni1178

9. Firstova VV, Mokrievich AN, Pavlov VM, et al. Immunological Markers that Correlate with Protection Immunity Against Tularemia Infection. Advances in Experimental Medicine and Biology. 2014;808:15–23. doi: 10.1007/978-81-322-1774-9_2.

10. Afanasiev EN, Taran IF, Tyumentseva IS. Antigenic structure of Brucella. Messaging. I. Comparative evaluation of methods for the isolation of water-soluble antigens brutsell. Stavropol; 1986. (In Russ.)